Selected Publications
Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT.: Impact of insurance status on MRI phenotypes in MS Mult Scler Relat Disord 92 (105919): 2024.
Oh J, Smolders J, Buijs F, Meyer zu Hörste G, Perrone C, van den Brand J, Federer-Gsponer J, Pedotti R, Kaczmarek L, Sharma V, Heinzmann D, Tackenberg B, Bar-Or A, Wiendl H: Defining PIRA and Lack of Disease Stability in the Real-World: Interim Results European Committee for Treatment and Research in Multiple Sclerosis : 2024.
Baller EB, Sweeney EM, Cieslak MC, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD: Mapping the relationship of white matter lesions to depression in multiple sclerosis Biol Psychiatry 95 (12): 1072-1080,2024.
Son JY, Hu C, McAlpine L, Bar-Or A, Dahl M, Brito SF, Kavak K, Onomichi K, Perrone C, Riley C, Song E, Walker E, Weinstock-Guttmen B, De Jager P, Longbrake E, Xia Z: Post-COVID conditions in people with multiple sclerosis: A cross-sectional multicenter study American Academy of Neurology : 2024.
Riley C, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, MSReCOV investigators, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis: A case-control cross-sectional and longitudinal analysis JMIR Public Health Surveill 10 (e45429): 2024.
Thebault S, Yamashita L, Breville G, Espinoza D, McGoldrick T, Woodson Z, Vitone M, Gandelman S, Windle A, Kadri J, Rezk A, Kim Y, Soldan S, Perrone CM, Jacobs D, Markowitz C, Jefferson A, Schindler M, Bar-Or A: Tandem CSF and blood flow-cytometric immune-cell profiling in the evaluation of neuroinflammatory conditions Americas Committee for Treatment and Research in Multiple Sclerosis : 2024.
Kim E, Lane C, McCabe K, Gandelman S, Rivera-Torres N, Kakara M, Brandstadter R, Perrone C, Schindler M, Orthmann-Murphy J, Markowitz C, Berger J, Bar-Or A, Perrone E, Noon A, Johnson D, Carmolingo A, Fuller R, Lenzi K, Lee J, Mozes J, Leibowitz L, Pileggi C, Garabedian M, Zeccardi S, Sekella N, Samudralwar R, Stein L, Price R, Jacobs D: Penn multiple sclerosis and related disorders center’s approach towards addressing disparities in care in resident clinic American Neurological Association : 2023.
Baller E, Sweeney E, Bar-Or A, Cieslak M, Covitz S, Detre J, Elahi A, Manning A, Markowitz C, Martin M, Perrone C, Rautman V, Robert-Fitzgerald T, Schindler M, Siddiqi S, Thomas S, Fox M, Shinohara R, Satterthwaite T: Depression as a disease of white matter network disruption: Characterizing the relationship between white matter lesions and depression in patients with multiple sclerosis Biol Psychiatry 93 (9): S117,2023.
Venkatesh S, Riley C, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis American Academy of Neurology 100 (17 Supplement 2): P12-3.001,2023.
Jakimovski D, Kavak KS, Longbrake EE, Levit E, Perrone CM, Bar-Or A, Benedict RHB, Riley CS, De Jager PL, Venkatesh S, Walker ELS, Xia Z, Weinstock-Guttman B: Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic Mult Scler Relat Disord 68 : 104235.,2022.
Academic Contact Information
3400 Spruce Street, 3 W. Gates Building
Philadelphia,
PA
19104
Phone: 215-662-3606
Patient appointments: 800-789-7366